引用本文:汤 力,韩 伟,孙 兴.微创插植放疗在不能切除胸腹腔恶性肿瘤中的临床应用[J].中国临床新医学,2009,2(8):817-819.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1063次   下载 739 本文二维码信息
码上扫一扫!
分享到: 微信 更多
微创插植放疗在不能切除胸腹腔恶性肿瘤中的临床应用
汤 力,韩 伟,孙 兴
530022 南宁,广西南宁市第一人民医院普外科
摘要:
[摘要] 目的 探讨微创插植放射性125I粒子在不能切除的胸腹腔肿瘤中临床应用的可行性。方法 回顾性分析96例Ⅲ期肺癌、中晚期肝癌及胰腺癌B超、CT、腔镜等引导插植放疗微创方法的疗效。结果 96例病人经治疗后,完全缓解19例,部分缓解39例,无变化21例,继续进展17例,病人生活质量提高,无放射性粒子迁移或排出体外,随访1~5年,存活57例,存活患者中,最长者已达5年,死亡39例。结论 微创插植放射性125I粒子对中晚期不能切除胸腹腔恶性肿瘤有较好的治疗效果。
关键词:  微创  插植放疗  肿瘤  125I粒子
DOI:10.3969/j.issn.1674-3806.2009.08.15
分类号:R 817.8
基金项目:
Clinical application of micro-invasive implant radiotherapy in unresectable splanchnocoel malignant tumors
TANG Li, HAN Wei, SUN Xin
The First People′s Hospital of Nanning, Nanning 530022, China
Abstract:
[Abstract] Objective To study the feasibility of clinical application of micro-invasive implanted radial 125I particle in unresectable splanchnocoel malignant tumors. Methods Retrospective analysis was applied in 96 cases with stage Ⅲlung cancer, or intermediate(advanced) hepatocellular carcinoma/pancreatic carcinoma who had been treated with micro-invasive implant radiotherapy guided by brightness mode, CT and endoscope.Results After treatment, within 96 cases, there were 19 cases of complete remission, 39 of partial remission, 21 of non-remission and 17 of progression. The life quality of patients was improved, and there was no transfer or discharge of radioactive particles in vitro. The follow-up investigation of patients for 1~5 years showed that 39 cases died and 57 cases survived, some of which had reached the maximum 5 years after treatment.Conclusion The micro-invasive implant radial 125I particle shows a good therapeutic efficacy in unresectable splanchnocoel malignant tumors of intermediate and advanced stage.
Key words:  Micro-invasive  Implant radiotherapy  Tumor  125I particle